Skip to Main content Skip to Navigation
Journal articles

Evaluation of Minimal Residual Disease (MRD) By Next Generation Sequencing (NGS) Is Highly Predictive of Progression Free Survival in the IFM/DFCI 2009 Trial

Abstract : 57th Annual Meeting of the American-Society-of-Hematology Location: Orlando, FL Date: DEC 05-08, 2015
Document type :
Journal articles
Complete list of metadatas

https://hal-univ-rennes1.archives-ouvertes.fr/hal-01300806
Contributor : Laurent Jonchère <>
Submitted on : Monday, April 11, 2016 - 2:15:00 PM
Last modification on : Wednesday, August 19, 2020 - 11:17:12 AM

Identifiers

  • HAL Id : hal-01300806, version 1

Citation

Herve Avet-Loiseau, Jill Corre, Valérie Lauwers-Cances, Marie-Lorraine Chretien, Nelly Robillard, et al.. Evaluation of Minimal Residual Disease (MRD) By Next Generation Sequencing (NGS) Is Highly Predictive of Progression Free Survival in the IFM/DFCI 2009 Trial. Blood, American Society of Hematology, 2015, 126 (23), pp.191. ⟨hal-01300806⟩

Share

Metrics

Record views

407